Aker Christopher Ray (CIK 1762611) reported 4 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-06-27). Recent activity: Sell RGLS (60,796 shares), Sell RGLS (83,125 shares), Sell RGLS (38,547 shares), Sell RGLS (5,088 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-06-27 | Regulus Therapeutics Inc. (RGLS) | Sr. VP & General Counsel | Sell | 60,796 | $0 |
| 2025-06-27 | Regulus Therapeutics Inc. (RGLS) | Sr. VP & General Counsel | Sell | 83,125 | $0 |
| 2025-01-15 | Regulus Therapeutics Inc. (RGLS) | Sr. VP & General Counsel | Sell | 38,547 | $48,569 |
| 2025-01-15 | Regulus Therapeutics Inc. (RGLS) | Sr. VP & General Counsel | Sell | 5,088 | $6,411 |
Source: SEC Form 4 filings · as of 2025-06-27